Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.56 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.51 |
| ▸ | TSHR | P16473 | 4/20 | 0.51 |
| ▸ | RECQL | P46063 | 1/20 | 0.51 |
| ▸ | MPI | P34949 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CRHBP | P24387 | 1/20 | 0.40 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3461918 | 0.86 | CYP3A4 (0.51) | CYP3A4TRPA1ALDH1A1TSHRRECQL | |
| SCHEMBL8677779 | 0.85 | CYP3A4 (0.49) | CYP3A4TRPA1ALDH1A1TSHRRECQL | |
| SCHEMBL3284296 | 0.85 | ALDH1A1 (0.50) | CYP3A4TRPA1ALDH1A1TSHRRECQL | |
| SCHEMBL11220630 | 0.84 | TSHR (0.47) | CYP3A4TRPA1ALDH1A1TSHRMAPK1 | |
| SCHEMBL29389795 | 0.81 | CYP3A4 (0.49) | CYP3A4TRPA1ALDH1A1TSHRMAPK1 | |
| SCHEMBL124224 | 0.81 | CYP3A4 (0.49) | CYP3A4TRPA1ALDH1A1TSHRMAPK1 | |
| SCHEMBL78800 | 0.79 | ALDH1A1 (0.53) | CYP3A4TRPA1ALDH1A1TSHRRECQL | |
| SCHEMBL15371322 | 0.79 | ALDH1A1 (0.56) | CYP3A4ALDH1A1TSHRRECQLMPI | |
| SCHEMBL1020966 | 0.79 | TDP1 (0.59) | ALDH1A1TSHRRECQLMAPK1TDP1 | |
| SCHEMBL10883032 | 0.79 | MEN1 (0.59) | ALDH1A1TSHRRECQLHSD17B10MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113750651-B | Filter material with antibacterial and deodorizing functions and preparation method thereof | 杭州巴贝克科技有限公司 | 2023-04-18 | — | — | CN | claimed |
| CN-113750651-A | Filter material with antibacterial and deodorizing functions and preparation method thereof | 杭州巴贝克科技有限公司 | 2021-12-07 | — | — | CN | claimed |
| CN-103304446-B | Derivatization method of optically active phenylacetylene compound | UNIV HARBIN ENG | 2015-02-25 | — | — | CN | claimed |
| CN-103304446-A | Derivatization method of optically active phenylacetylene compound | UNIV HARBIN ENG | 2013-09-18 | — | — | CN | claimed |
| CN-113750651-B | Filter material with antibacterial and deodorizing functions and preparation method thereof | 杭州巴贝克科技有限公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-113750651-A | Filter material with antibacterial and deodorizing functions and preparation method thereof | 杭州巴贝克科技有限公司 | 2021-12-07 | — | — | CN | disclosed |
| EP-3296309-B1 | GALACTOPYRANOSYL DERIVATIVES USEFUL AS MEDICAMENTS | UNIV GENT (BE) | 2019-08-07 | — | — | EP | disclosed |
| EP-3354646-A1 | ISOINDOLINE COMPOUNDS FOR USE IN THE TREATMENT OF CANCER | Celgene Corporation (US) | 2018-08-01 | — | — | EP | disclosed |
| EP-3296309-A1 | GALACTOPYRANOSYL DERIVATIVES USEFUL AS MEDICAMENTS | Universiteit Gent (BE) | 2018-03-21 | — | — | EP | disclosed |
| EP-2985281-B1 | ISOINDOLINE COMPOUNDS FOR USE IN THE TREATMENT OF CANCER | CELGENE CORP (US) | 2017-12-27 | — | — | EP | disclosed |
| US-9796698-B2 | Isoindoline compounds and methods of their use | CELGENE CORPORATION (US) | 2017-10-24 | — | — | US | disclosed |
| EP-2877480-B1 | GALACTOPYRANOSYL DERIVATIVES USEFUL AS MEDICAMENTS | UNIV GENT (BE) | 2017-09-06 | — | — | EP | disclosed |
| US-4147801-A | UREYLENEBIS/METHYL-PHENYLENE/UREYLENE//DI-1,3,6-NAPHTHALENE TRISULFONIC ACID | AMERICAN CYANAMID COMPANY (US) | 1979-04-03 | — | — | US | disclosed |
| US-4146640-A | SULFONIC ACID AND SECONDARY AMIDE FUNCTIONAL GROUPS | AMERICAN CYANAMID COMPANY (US) | 1979-03-27 | — | — | US | disclosed |
| US-4108890-A | Nitro or amino phenylenebis(carbonylimino)dinaphthalenetrisulfonic compounds as complement inhibitors | AMERICAN CYANAMID COMPANY (US) | 1978-08-22 | — | — | US | disclosed |
| US-4103028-A | SUBSTITUTED HYDROXY NAPHTHALENEDISULFONIC ACIDS | AMERICAN CYANAMID COMPANY (US) | 1978-07-25 | — | — | US | disclosed |
| US-4087548-A | NAPHTHALENE TRISULFONIC ACIDS | AMERICAN CYANAMID COMPANY (US) | 1978-05-02 | — | — | US | disclosed |
| US-4070391-A | Process for producing isocyanate from nitro compounds and carbon monoxide using rhodium oxide catalysts | ETHYL CORPORATION (US) | 1978-01-24 | — | — | US | disclosed |
| US-4051176-A | COMPLEMENT INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1977-09-27 | — | — | US | disclosed |
| US-4046805-A | Substituted-hydroxy-naphthalenedisulfonic acid compounds | AMERICAN CYANAMID COMPANY (US) | 1977-09-06 | — | — | US | disclosed |